{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:27:53Z","timestamp":1791822473180,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["rep.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fifty to seventy percent of patients with polycystic ovary syndrome (PCOS) present hyperinsulinemia. On the other hand, reports indicate that forkhead box class O 1 (FOXO1) and peroxisome proliferator-activated receptor-\u03b3 (PPARG) are involved in the insulin signaling pathway, regulating the gene expression of SLC2A4 (GLUT4). The negative effect of FOXO1 over PPARG transcription disappears when FOXO1 is phosphorylated (p-FOXO1) and excluded from the nucleus, whereas PPARG can suppress gene expression of SLC2A4. Scarce knowledge is available in endometrium of women with PCOS and hyperinsulinemia (PCOSE h-Ins) about the role of these factors. We aimed to evaluate whether the endocrine and metabolic status of PCOS modify the levels of gene and protein expression of FOXO1, PPARG, and SLC2A4 in the endometria from hyperinsulinemic PCOS women compared with controls. In endometria from control (CE, n=7) or PCOSE h-Ins (n=7), we determined the subcellular location and protein levels of p-FOXO1Ser319 and FOXO1\/FOXO4 by immunohistochemistry and western blot respectively; gene and\/or protein levels of PPARG and SLC2A4 were evaluated by RT-PCR and\/or western blot. Cytoplasm location for FOXO1 and p-FOXO1Ser319 was immunodetected in both groups of endometria, showing significantly higher staining in PCOSE h-Ins for these proteins (P&amp;lt;0.05). In PCOSE h-Ins, gene and protein levels of PPARG were significantly higher than in CE, whereas SLC2A4 mRNA was decreased (P&amp;lt;0.05). In conclusion, the derepression of PPARG transcription by the high levels of p-FOXO1Ser319 could partially account for the lower levels of SLC2A4 found in PCOSE h-Ins, suggesting an alteration of the endometrial function in these patients.<\/jats:p>","DOI":"10.1530\/rep-10-0056","type":"journal-article","created":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T22:26:07Z","timestamp":1271802367000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":41,"title":["Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome"],"prefix":"10.1093","volume":"140","author":[{"given":"Karla","family":"Kohan","sequence":"first","affiliation":[{"name":"Laboratory of Endocrinology and Reproductive Biology University of Chile Clinical Hospital, Santos Dumont # 999, Independencia, Santiago 838-0456, Chile 2Department of Pathology School of Medicine, San Borja Arriar\u00e1n Clinical Hospital, University of Chile, Santiago 832-0000, Chile 3Department of Obstetrics and Gynecology School of Medicine, University of Chile Clinical Hospital, Santiago 838-0456, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Carvajal","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Reproductive Biology University of Chile Clinical Hospital, Santos Dumont # 999, Independencia, Santiago 838-0456, Chile 2Department of Pathology School of Medicine, San Borja Arriar\u00e1n Clinical Hospital, University of Chile, Santiago 832-0000, Chile 3Department of Obstetrics and Gynecology School of Medicine, University of Chile Clinical Hospital, Santiago 838-0456, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gabler","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Reproductive Biology University of Chile Clinical Hospital, Santos Dumont # 999, Independencia, Santiago 838-0456, Chile 2Department of Pathology School of Medicine, San Borja Arriar\u00e1n Clinical Hospital, University of Chile, Santiago 832-0000, Chile 3Department of Obstetrics and Gynecology School of Medicine, University of Chile Clinical Hospital, Santiago 838-0456, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vantman","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Reproductive Biology University of Chile Clinical Hospital, Santos Dumont # 999, Independencia, Santiago 838-0456, Chile 2Department of Pathology School of Medicine, San Borja Arriar\u00e1n Clinical Hospital, University of Chile, Santiago 832-0000, Chile 3Department of Obstetrics and Gynecology School of Medicine, University of Chile Clinical Hospital, Santiago 838-0456, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Romero","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Reproductive Biology University of Chile Clinical Hospital, Santos Dumont # 999, Independencia, Santiago 838-0456, Chile 2Department of Pathology School of Medicine, San Borja Arriar\u00e1n Clinical Hospital, University of Chile, Santiago 832-0000, Chile 3Department of Obstetrics and Gynecology School of Medicine, University of Chile Clinical Hospital, Santiago 838-0456, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Vega","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Reproductive Biology University of Chile Clinical Hospital, Santos Dumont # 999, Independencia, Santiago 838-0456, Chile 2Department of Pathology School of Medicine, San Borja Arriar\u00e1n Clinical Hospital, University of Chile, Santiago 832-0000, Chile 3Department of Obstetrics and Gynecology School of Medicine, University of Chile Clinical Hospital, Santiago 838-0456, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"key":"2026010712530279600_bib1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00125-005-1741-3","article-title":"Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1","volume":"48","author":"Al-Khalili","year":"2005","journal-title":"Diabetologia"},{"key":"2026010712530279600_bib2","doi-asserted-by":"crossref","first-page":"30614","DOI":"10.1074\/jbc.M304654200","article-title":"Peroxisome proliferator-activated receptor-\u03b3 represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect","volume":"278","author":"Armoni","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"2026010712530279600_bib3","doi-asserted-by":"crossref","first-page":"19881","DOI":"10.1074\/jbc.M600320200","article-title":"FOXO1 represses peroxisome proliferator-activated receptor-\u03b31 and -\u03b32 gene promoters in primary adipocytes","volume":"281","author":"Armoni","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"2026010712530279600_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tem.2007.02.001","article-title":"Transcriptional regulation of the GLUT4 gene: from PPAR-\u03b3 and FOXO1 to FFA and inflammation","volume":"18","author":"Armoni","year":"2007","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"2026010712530279600_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cellsig.2006.08.015","article-title":"Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate FOXO1","volume":"19","author":"Asada","year":"2007","journal-title":"Cellular Signalling"},{"key":"2026010712530279600_bib6","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/humrep\/del183","article-title":"Expresi\u00f3n of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary s\u00edndrome","volume":"21","author":"Avellaira","year":"2006","journal-title":"Human Reproduction"},{"key":"2026010712530279600_bib7","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2026010712530279600_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsbmb.2008.03.031","article-title":"In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"110","author":"Bacallao","year":"2008","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"2026010712530279600_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanism","volume":"4","author":"Calle","year":"2004","journal-title":"Nature Reviews. Cancer"},{"key":"2026010712530279600_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0015-0282(02)03304-6","article-title":"Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis","volume":"78","author":"Castro","year":"2002","journal-title":"Fertility and Sterility"},{"key":"2026010712530279600_bib43","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0015-0282(01)02843-6","article-title":"Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone","volume":"76","author":"Cataldo","year":"2001","journal-title":"Fertility and Sterility"},{"key":"2026010712530279600_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends in Molecular Medicine"},{"key":"2026010712530279600_bib12","first-page":"774","article-title":"Insulin resistance and the polycyctic ovarian syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocrine Reviews"},{"key":"2026010712530279600_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2026010712530279600_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2119\/molmed.2009.00118","article-title":"Changes in the expression of insulin signaling pathway molecules in endometria from PCOS women with or without hyperinsulinemia","volume":"16","author":"Fornes","year":"2010","journal-title":"Molecular Medicine"},{"key":"2026010712530279600_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/PPAR\/2006\/73986","article-title":"Thiazolidinediones and fertility in polycystic ovary syndrome (PCOS)","volume":"2006","author":"Froment","year":"2006","journal-title":"PPAR Research"},{"key":"2026010712530279600_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1677\/joe.1.06667","article-title":"Peroxisome proliferator activated receptors in reproductive tissues: from gametogenesis to parturition","volume":"189","author":"Froment","year":"2006","journal-title":"Journal of Endocrinology"},{"key":"2026010712530279600_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"2026010712530279600_bib18","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/onc.2008.25","article-title":"The role of FoxO in the regulation of metabolism","volume":"27","author":"Gross","year":"2008","journal-title":"Oncogene"},{"key":"2026010712530279600_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-08-0507","article-title":"Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome","volume":"159","author":"Jensterle","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"2026010712530279600_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2007.09.017","article-title":"PPAR-\u03b3 agonists \u2013 antidiabetic drugs with a potential role in the treatment of diseases other than diabetes","volume":"78","author":"Jermendy","year":"2007","journal-title":"Diabetes Research and Clinical Practice"},{"key":"2026010712530279600_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1152\/ajpendo.90306.2008","article-title":"Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology","volume":"295","author":"Karnieli","year":"2008","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"2026010712530279600_bib22","doi-asserted-by":"crossref","first-page":"402.e1","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","author":"Legro","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026010712530279600_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.steroids.2007.03.001","article-title":"Effect of estrogen and inhibition of phosphatidylinositol-3 kinase on Akt and FOXO1 in rat uterus","volume":"72","author":"Lengyel","year":"2007","journal-title":"Steroids"},{"key":"2026010712530279600_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.steroids.2007.09.003","article-title":"Activities of steroid metabolic enzymes in secretory endometria from untreated women with polycystic ovary syndrome","volume":"73","author":"Le\u00f3n","year":"2008","journal-title":"Steroids"},{"key":"2026010712530279600_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jcem-67-2-334","article-title":"Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle","volume":"67","author":"Lessey","year":"1988","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2026010712530279600_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0015-0282(03)00987-7","article-title":"Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome","volume":"80","author":"Maliqueo","year":"2003","journal-title":"Fertility and Sterility"},{"key":"2026010712530279600_bib27","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/humrep\/deg482","article-title":"Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of \u03b2-cell dysfunction?","volume":"18","author":"Maliqueo","year":"2003","journal-title":"Human Reproduction"},{"key":"2026010712530279600_bib28","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1210\/jc.2003-032028","article-title":"Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients","volume":"89","author":"Mioni","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2026010712530279600_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.febslet.2007.11.025","article-title":"The FoxO transcription factors and metabolic regulation","volume":"582","author":"Nakae","year":"2008","journal-title":"FEBS Letters"},{"key":"2026010712530279600_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the edometrial biopsy","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertility and Sterility"},{"key":"2026010712530279600_bib31","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-05-1833","article-title":"Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma","volume":"12","author":"Ota","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"2026010712530279600_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.nutr.22.010402.102808","article-title":"PPAR-\u03b3 and glucose homeostasis","volume":"22","author":"Picard","year":"2002","journal-title":"Annual Review of Nutrition"},{"key":"2026010712530279600_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2004.11.005","article-title":"Evidence-based care of recurrent miscarriage","volume":"19","author":"Porter","year":"2005","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"key":"2026010712530279600_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000053281","article-title":"Association of insulin resistance with hyperandrogenia in women","volume":"54","author":"Pugeat","year":"2000","journal-title":"Hormone Research"},{"key":"2026010712530279600_bib35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.fertnstert.2005.09.053","article-title":"Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome","volume":"85","author":"Quezada","year":"2006","journal-title":"Fertility and Sterility"},{"key":"2026010712530279600_bib36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanism of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"key":"2026010712530279600_bib37","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"POSITION STATEMENT: glucose intolerance in polycystic ovary syndrome \u2013 a Position Statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2026010712530279600_bib38","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1210\/jc.2005-0469","article-title":"Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production","volume":"90","author":"Seto-Young","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2026010712530279600_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS and Consensus Workshop Group","year":"2004","journal-title":"Fertility and Sterility"},{"key":"2026010712530279600_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2009.06.033","article-title":"Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome","volume":"115","author":"Villavicencio","year":"2009","journal-title":"Gynecologic Oncology"},{"key":"2026010712530279600_bib41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbalip.2007.01.008","article-title":"Transcription coactivators for peroxisome proliferator-activated receptors","volume":"1771","author":"Yu","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"key":"2026010712530279600_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.febslet.2007.11.081","article-title":"Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR\u2013RXR complex","volume":"582","author":"Ziouzenkova","year":"2008","journal-title":"FEBS Letters"}],"container-title":["Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/140\/1\/123.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/140\/1\/123\/64531307\/123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/140\/1\/123\/64531307\/123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:57:41Z","timestamp":1767808661000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/reproduction\/article\/140\/1\/123\/8243241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/rep-10-0056","relation":{},"ISSN":["1470-1626","1741-7899"],"issn-type":[{"value":"1470-1626","type":"print"},{"value":"1741-7899","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,7,1]]},"published":{"date-parts":[[2010,7,1]]}}}